HRP940315B1 - Process for the preparation of pharmaceutical compositions containinbg active ingredient - Google Patents
Process for the preparation of pharmaceutical compositions containinbg active ingredientInfo
- Publication number
- HRP940315B1 HRP940315B1 HR940315A HRP940315A HRP940315B1 HR P940315 B1 HRP940315 B1 HR P940315B1 HR 940315 A HR940315 A HR 940315A HR P940315 A HRP940315 A HR P940315A HR P940315 B1 HRP940315 B1 HR P940315B1
- Authority
- HR
- Croatia
- Prior art keywords
- containinbg
- preparation
- active ingredient
- pharmaceutical compositions
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310756A GB9310756D0 (en) | 1993-05-25 | 1993-05-25 | Compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP940315A2 HRP940315A2 (en) | 1996-08-31 |
| HRP940315B1 true HRP940315B1 (en) | 2000-12-31 |
Family
ID=10736089
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR940315A HRP940315B1 (en) | 1993-05-25 | 1994-05-23 | Process for the preparation of pharmaceutical compositions containinbg active ingredient |
| HR970315A HRP970315A2 (en) | 1993-05-25 | 1997-06-09 | Angular adjustment of compression |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR970315A HRP970315A2 (en) | 1993-05-25 | 1997-06-09 | Angular adjustment of compression |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US5741806A (is) |
| EP (1) | EP0700290B1 (is) |
| JP (1) | JP2965703B2 (is) |
| KR (1) | KR100297212B1 (is) |
| CN (1) | CN1106194C (is) |
| AP (1) | AP544A (is) |
| AT (1) | ATE183643T1 (is) |
| AU (1) | AU680918B2 (is) |
| BE (1) | BE1007158A3 (is) |
| BR (1) | BR1100046A (is) |
| CA (1) | CA2162919C (is) |
| CO (1) | CO4230094A1 (is) |
| CY (1) | CY2411B1 (is) |
| CZ (1) | CZ291041B6 (is) |
| DE (1) | DE69420266T2 (is) |
| DK (1) | DK0700290T3 (is) |
| EC (1) | ECSP941088A (is) |
| ES (1) | ES2136198T3 (is) |
| FR (1) | FR2705569B1 (is) |
| GB (2) | GB9310756D0 (is) |
| GR (1) | GR3031669T3 (is) |
| HR (2) | HRP940315B1 (is) |
| HU (1) | HU227121B1 (is) |
| IE (1) | IE80632B1 (is) |
| IL (1) | IL109749A (is) |
| IS (1) | IS1868B (is) |
| IT (1) | IT1272990B (is) |
| MY (1) | MY111445A (is) |
| NO (1) | NO306448B1 (is) |
| NZ (1) | NZ267415A (is) |
| PE (1) | PE13395A1 (is) |
| PL (1) | PL175578B1 (is) |
| RU (1) | RU2132684C1 (is) |
| SA (1) | SA94150003B1 (is) |
| SG (1) | SG48119A1 (is) |
| SI (1) | SI0700290T1 (is) |
| WO (1) | WO1994027599A1 (is) |
| ZA (1) | ZA943593B (is) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK19062000A3 (sk) * | 1998-06-15 | 2001-07-10 | Sepracor, Inc. | Použitie (-)-norcisapridu alebo jeho farmaceuticky prijateľnej soli, v podstate bez jeho (+) stereoizoméru, na liečenie apnoe, bulímie a iných porúch |
| EP1468685A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| EP1464333A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders |
| TR200103056T2 (tr) | 1998-06-15 | 2002-06-21 | Sepracor Inc. | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (+)-norsisapridin kullanımı. |
| US6362202B1 (en) | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| US6353005B1 (en) | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
| US6555543B2 (en) * | 2000-08-04 | 2003-04-29 | Dmi Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR920003064B1 (ko) * | 1984-01-25 | 1992-04-13 | 글락소 그룹 리미티드 | 헤테로시클릭 화합물의 제조방법 |
| US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| GB8627909D0 (en) * | 1986-11-21 | 1986-12-31 | Glaxo Group Ltd | Medicaments |
| GB8816187D0 (en) * | 1988-07-07 | 1988-08-10 | Glaxo Group Ltd | Medicaments |
| US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
-
1993
- 1993-05-25 GB GB939310756A patent/GB9310756D0/en active Pending
-
1994
- 1994-05-17 GB GB9409835A patent/GB2279008B/en not_active Expired - Lifetime
- 1994-05-17 EC EC1994001088A patent/ECSP941088A/es unknown
- 1994-05-17 SG SG1996007139A patent/SG48119A1/en unknown
- 1994-05-19 IS IS4168A patent/IS1868B/is unknown
- 1994-05-20 MY MYPI94001305A patent/MY111445A/en unknown
- 1994-05-23 PE PE1994242905A patent/PE13395A1/es not_active IP Right Cessation
- 1994-05-23 CO CO94021615A patent/CO4230094A1/es unknown
- 1994-05-23 AP APAP/P/1994/000643A patent/AP544A/en active
- 1994-05-23 IE IE940420A patent/IE80632B1/en not_active IP Right Cessation
- 1994-05-23 HR HR940315A patent/HRP940315B1/xx not_active IP Right Cessation
- 1994-05-24 IL IL10974994A patent/IL109749A/en not_active IP Right Cessation
- 1994-05-24 HU HU9503375A patent/HU227121B1/hu unknown
- 1994-05-24 SI SI9430263T patent/SI0700290T1/xx unknown
- 1994-05-24 CN CN94192243A patent/CN1106194C/zh not_active Expired - Lifetime
- 1994-05-24 ZA ZA943593A patent/ZA943593B/xx unknown
- 1994-05-24 ES ES94918355T patent/ES2136198T3/es not_active Expired - Lifetime
- 1994-05-24 RU RU95122578A patent/RU2132684C1/ru active
- 1994-05-24 AU AU69709/94A patent/AU680918B2/en not_active Expired
- 1994-05-24 BE BE9400528A patent/BE1007158A3/fr not_active IP Right Cessation
- 1994-05-24 DE DE69420266T patent/DE69420266T2/de not_active Expired - Lifetime
- 1994-05-24 AT AT94918355T patent/ATE183643T1/de active
- 1994-05-24 JP JP7500204A patent/JP2965703B2/ja not_active Expired - Lifetime
- 1994-05-24 WO PCT/EP1994/001652 patent/WO1994027599A1/en active IP Right Grant
- 1994-05-24 CA CA002162919A patent/CA2162919C/en not_active Expired - Lifetime
- 1994-05-24 CZ CZ19953085A patent/CZ291041B6/cs not_active IP Right Cessation
- 1994-05-24 NZ NZ267415A patent/NZ267415A/en not_active IP Right Cessation
- 1994-05-24 FR FR9406252A patent/FR2705569B1/fr not_active Expired - Lifetime
- 1994-05-24 PL PL94311721A patent/PL175578B1/pl unknown
- 1994-05-24 IT ITRM940322A patent/IT1272990B/it active IP Right Grant
- 1994-05-24 US US08/537,950 patent/US5741806A/en not_active Expired - Lifetime
- 1994-05-24 EP EP94918355A patent/EP0700290B1/en not_active Expired - Lifetime
- 1994-05-24 KR KR1019950705280A patent/KR100297212B1/ko not_active IP Right Cessation
- 1994-05-24 DK DK94918355T patent/DK0700290T3/da active
- 1994-06-12 SA SA94150003A patent/SA94150003B1/ar unknown
-
1995
- 1995-11-24 NO NO954783A patent/NO306448B1/no not_active IP Right Cessation
-
1996
- 1996-09-19 BR BR1100046-5A patent/BR1100046A/pt active IP Right Grant
-
1997
- 1997-06-09 HR HR970315A patent/HRP970315A2/hr not_active Application Discontinuation
-
1999
- 1999-10-27 GR GR990402759T patent/GR3031669T3/el unknown
-
2000
- 2000-06-06 CY CY0000022A patent/CY2411B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT59106A (en) | Process for producing 3-amidopyrazoles and pharmaceutical compositions comprising such compounds as active ingredient | |
| HUT64065A (en) | Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
| EP0727217A3 (en) | Pharmaceutical and cosmetic compositions containing God-type ellagitannin as an active ingredient | |
| HUT46654A (en) | Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient | |
| ZA965866B (en) | 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
| HK1001860A1 (en) | I-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
| HUT52089A (en) | Process for producing triazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| HUT49625A (en) | Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient | |
| HUT60466A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient | |
| HUT56270A (en) | Process for producing taxol derivatives and pharmaceutical compositions comprising such active ingredient | |
| HU896444D0 (en) | Process for the preparation of pharmaceutical compositions | |
| IL107978A0 (en) | Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUT64013A (en) | Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| HUT64082A (en) | Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient | |
| HUT56359A (en) | Process for producing leukotriene antagonist compounds and pharmaceutical compositions comprising same as active ingredient | |
| IL107358A0 (en) | a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
| HUT49370A (en) | Process for producing polypeptides and pharmaceutical compositions comprising same as active ingredient | |
| HUT46660A (en) | Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient | |
| HUT62593A (en) | Process for producing 3-deoxymannose amine derivatives and pharmaceutical compositions comprising such active ingredient | |
| HU895241D0 (en) | Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient | |
| HU900865D0 (en) | Fungicidal compositions comprising 2-anilino-cyanopyridines and process for preparation of the active ingredient | |
| HUP9601680A3 (en) | Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds | |
| ZA941088B (en) | Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them | |
| IL105406A0 (en) | Derivatives of adipogenesis inhibitory factor,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUT59917A (en) | Process for producing sulfonamide derivatives and pharmaceutical compositions containing them as active component |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| B1PR | Patent granted | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20130521 Year of fee payment: 20 |
|
| PB20 | Patent expired after termination of 20 years |
Effective date: 20140523 |